Fenofibrate prevents Rosiglitazone-induced body weight gain in ob/ob mice.
about
Activation of PPAR gamma induces profound multilocularization of adipocytes in adult mouse white adipose tissues.Distinct metabolic effects following short-term exposure of different high-fat diets in male and female miceLigand binding and activation of PPARγ by Firemaster® 550: effects on adipogenesis and osteogenesis in vitroConcurrent activation of liver X receptor and peroxisome proliferator-activated receptor alpha exacerbates hepatic steatosis in high fat diet-induced obese mice.Nuclear receptors in renal diseaseInhibition of ubiquitin ligase F-box and WD repeat domain-containing 7α (Fbw7α) causes hepatosteatosis through Krüppel-like factor 5 (KLF5)/peroxisome proliferator-activated receptor γ2 (PPARγ2) pathway but not SREBP-1c protein in mice.Effects of conjugated linoleic acid, fish oil and soybean oil on PPARs (α & γ) mRNA expression in broiler chickens and their relation to body fat depositsUpdate on Safety Issues Related to Antihyperglycemic TherapyReduction of Food Intake by Fenofibrate is Associated with Cholecystokinin Release in Long-Evans Tokushima Rats.Benzbromarone, an old uricosuric drug, inhibits human fatty acid binding protein 4 in vitro and lowers the blood glucose level in db/db mice.Investigational PPAR-gamma agonists for the treatment of Type 2 diabetes.PPARdelta Agonism for the Treatment of Obesity and Associated Disorders: Challenges and OpportunitiesMaintenance of adiponectin attenuates insulin resistance induced by dietary conjugated linoleic acid in mice.Latanoprost effectively ameliorates glucose and lipid disorders in db/db and ob/ob mice.Human multipotent adipose-derived stem cells differentiate into functional brown adipocytes.PPARs and Adipose Cell PlasticityCurrent and novel therapies for the treatment of nonalcoholic steatohepatitis.Resveratrol suppresses T0901317-induced hepatic fat accumulation in mice.Increase in weight induced by muraglitazar, a dual PPARalpha/gamma agonist, in db/db mice: adipogenesis/or oedema?Vanadyl acetylacetonate upregulates PPARγ and adiponectin expression in differentiated rat adipocytes.Coadministration of coenzyme Q prevents rosiglitazone-induced adipogenesis in ob/ob mice.Pharmacological Characterization of YM543, a Newly Synthesized, Orally Active SGLT2 Selective Inhibitor.Sex-dependent differences in rat hepatic lipid accumulation and insulin sensitivity in response to diet-induced obesity.
P2860
Q33575775-D6AC01E4-7DF1-492D-BD57-DAE90A4E451BQ33709596-D779DAAE-2F81-48DF-AF54-3A321BBA530CQ34435425-7BE796A6-F1B2-4480-89FB-C1E2E43C8496Q34770055-C7267E32-DEB0-45E6-8E68-588829E1E690Q35120702-D6852D12-D517-489E-8634-E2C843C53127Q35562476-15EFB799-0BE9-49DC-9438-6032F5D2F4B7Q35669453-26B51A14-F15B-4BF0-ABFE-F13142C5D327Q35910429-86B7DE3B-62F9-42B0-ACEA-78869A811B27Q36089785-0AD5994E-8BED-41F5-AE70-135A839395BAQ36294824-2FDB2348-3BD6-4CE2-BA1D-AD1A273C21D3Q36512559-20161F60-2292-4F90-ACF2-D52714B6A73FQ36959065-2B12C4A7-418D-4596-BBCC-EFB8003A6BA0Q38308383-716CA87D-FFD1-455B-8A16-4D54F43F87E0Q38313005-8E8AE7A5-F2F1-4081-86F8-BD671DA9ADDDQ39809960-6830A0FF-2B8C-45F9-900F-5C492F2926F0Q41828567-0825003B-03DA-44BD-A29C-8337B4416FE9Q41832154-9CF96202-CB7C-411F-9DB7-F4AEE55BFEA5Q42711881-0988DC13-7D8B-48DD-933A-B3D21045B06CQ42797804-8253436B-7149-40E4-A30B-6359EFE8077AQ43435300-81945966-9676-4964-92A8-5E6C82EC9DEDQ46174247-8C071E37-3620-426A-AE31-743CD0DB60A5Q46773908-C0BCA877-1416-430B-B18F-51CFCB4DE033Q51368985-F25661C9-9C39-48F0-9B2B-42B3BCC1CC6F
P2860
Fenofibrate prevents Rosiglitazone-induced body weight gain in ob/ob mice.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
Fenofibrate prevents Rosiglitazone-induced body weight gain in ob/ob mice.
@en
type
label
Fenofibrate prevents Rosiglitazone-induced body weight gain in ob/ob mice.
@en
prefLabel
Fenofibrate prevents Rosiglitazone-induced body weight gain in ob/ob mice.
@en
P2093
P2860
P356
P1476
Fenofibrate prevents Rosiglitazone-induced body weight gain in ob/ob mice
@en
P2093
Carmona MC
Desbazeille M
Nibbelink M
Pénicaud L
P2860
P2888
P304
P356
10.1038/SJ.IJO.0802943
P407
P50
P577
2005-07-01T00:00:00Z
P5875
P6179
1002080567